Close the sale of the Chelsea manufacturing operations to Catalent
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 13 Jan 2021
- Due
- 31 Mar 2021
- Delivered
- 10 Feb 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Completion of the transaction is subject to customary closing conditions and is expected to occur in the first quarter of 2021.”
What we found
Evidence strength A What the grades mean
Acorda Therapeutics completed the sale of its Chelsea manufacturing operations to Catalent on February 10, 2021, which is within the first quarter of 2021.
-
A Acorda Therapeutics Inc. 10-Q filed 2021-05-12
“On February 10, 2021, we completed the sale of our Chelsea, Massachusetts manufacturing operations to Catalent Pharma Solutions.” ✓ confirmed on the page
Checked 24 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Acquisition close
- Indicative materiality
- High rules
- Action
- Close
- Deliverable
- Chelsea manufacturing operations sale
- Where
- Massachusetts
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- Medium
- Specificity
- High
- Conditional
- Yes: customary closing conditions
- Depends on
- Counterparty
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Acorda Therapeutics Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-C008848-021994 · Corrections policy